Meggitt to Buy Danaher's Pacific Scientific Aerospace Business

Danaher Corporation (NYSE: DHR) announced today that it has signed a definitive agreement to sell its Pacific Scientific Aerospace business (other than the Artus business) to Meggitt PLC (LSE: MGGT), a global aerospace and defense company.

Danaher simultaneously received a binding offer from Meggitt to acquire the Artus business which remains open for 12 months. As required by French law, Danaher must consult with the Artus works council prior to concluding an agreement for the sale of the Artus business.

Upon the closing of both transactions, Meggitt will pay Danaher an aggregate cash purchase price of $685 million, subject to post-closing adjustments.

Danaher's Pacific Scientific Aerospace business is a leading supplier of electric power, electric linear actuation, safety and security products to both the commercial and military aerospace markets. In 2010, the business had revenues of approximately $378 million and contributed $0.07 to diluted earnings per share. The business will be treated as a discontinued operation for financial reporting purposes beginning in the first quarter of 2011.

The closing of the definitive agreement is subject to customary conditions, including regulatory approvals. The parties currently expect that the transactions will close in the second quarter of 2011.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.